<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33917816</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>20</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>08</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Potential Roles of the WNT Signaling Pathway in Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">839</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells10040839</ELocationID><Abstract><AbstractText>The WNT signaling pathway plays an important role in the physiological and pathophysiological processes of the central nervous system and the neurodegenerative disease amyotrophic lateral sclerosis (ALS). We reviewed the literature pertinent to WNT/&#x3b2;-catenin signaling in ALS from cellular studies, animal models, and human clinical trials. WNT, WNT receptors, and other components of the WNT signaling pathway are expressed in both ALS patients and transgenic mice, and are involved in the pathogenesis of ALS. Studies have shown that abnormal activation of the WNT/&#x3b2;-catenin signaling pathway is related to neuronal degeneration and glial cell proliferation. WNT/Ca<sup>2+</sup> signaling is associated with the pro-inflammatory phenotype of microglia; data on the muscle skeletal receptor Tyr kinase receptor in superoxide dismutase-1-G93A mice indicate that gene therapy is necessary for successful treatment of ALS. The varying profiles of lipoprotein receptor-related protein 4 antibodies in different ethnic groups suggest that individual treatment and multifactorial personalized approaches may be necessary for effective ALS therapy. In conclusion, the WNT signaling pathway is important to the ALS disease process, making it a likely therapeutic target.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Histology and Embryology, Neurologic Disorders and Regenerative Repair Laboratory, Weifang Medical University, Weifang 261053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Yingjun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Histology and Embryology, Neurologic Disorders and Regenerative Repair Laboratory, Weifang Medical University, Weifang 261053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Zhenhan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Histology and Embryology, Neurologic Disorders and Regenerative Repair Laboratory, Weifang Medical University, Weifang 261053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Fandi</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Histology and Embryology, Neurologic Disorders and Regenerative Repair Laboratory, Weifang Medical University, Weifang 261053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xuemei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Histology and Embryology, Neurologic Disorders and Regenerative Repair Laboratory, Weifang Medical University, Weifang 261053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Xueshuai</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Histology and Embryology, Neurologic Disorders and Regenerative Repair Laboratory, Weifang Medical University, Weifang 261053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jinmeng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Histology and Embryology, Neurologic Disorders and Regenerative Repair Laboratory, Weifang Medical University, Weifang 261053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yanchun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Histology and Embryology, Neurologic Disorders and Regenerative Repair Laboratory, Weifang Medical University, Weifang 261053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Fenghua</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Histology and Embryology, Neurologic Disorders and Regenerative Repair Laboratory, Weifang Medical University, Weifang 261053, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Weifang Medical University, Weifang 261053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Shuanhu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>81871006</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008024">Ligands</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051153">Wnt Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051153" MajorTopicYN="N">Wnt Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060449" MajorTopicYN="Y">Wnt Signaling Pathway</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">WNT signaling</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">glial cells</Keyword><Keyword MajorTopicYN="N">motor neurons</Keyword><Keyword MajorTopicYN="N">neuromuscular junctions</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>30</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33917816</ArticleId><ArticleId IdType="pmc">PMC8068170</ArticleId><ArticleId IdType="doi">10.3390/cells10040839</ArticleId><ArticleId IdType="pii">cells10040839</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson B., Gendron T.F., Staff N.P. Amyotrophic Lateral Sclerosis: An Update for 2018. Mayo Clin. Proc. 2018;93:1617&#x2013;1628. doi: 10.1016/j.mayocp.2018.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2018.04.007</ArticleId><ArticleId IdType="pubmed">30401437</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsitkanou S., Lindsay A., Della Gatta P. The role of skeletal muscle in amyotrophic lateral sclerosis: A &#x2018;dying-back&#x2019; or &#x2018;dying-forward&#x2019; phenomenon? J. Physiol. 2019;597:5527&#x2013;5528. doi: 10.1113/JP278835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP278835</ArticleId><ArticleId IdType="pubmed">31605390</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M., Pal A., Goswami A., Lojewski X., Japtok J., Vehlow A., Naujock M., G&#xfc;nther R., Jin M., Stanslowsky N., et al. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat. Commun. 2018;9:335. doi: 10.1038/s41467-017-02299-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02299-1</ArticleId><ArticleId IdType="pmc">PMC5780468</ArticleId><ArticleId IdType="pubmed">29362359</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp. Neurol. 2004;185:232&#x2013;240. doi: 10.1016/j.expneurol.2003.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadon-Nachum M., Melamed E., Offen D. The "dying-back" phenomenon of motor neurons in ALS. J. Mol. NeuroSci. 2011;43:470&#x2013;477. doi: 10.1007/s12031-010-9467-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-010-9467-1</ArticleId><ArticleId IdType="pubmed">21057983</ArticleId></ArticleIdList></Reference><Reference><Citation>Nusse R., Varmus H.E. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell. 1982;31:99&#x2013;109. doi: 10.1016/0092-8674(82)90409-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(82)90409-3</ArticleId><ArticleId IdType="pubmed">6297757</ArticleId></ArticleIdList></Reference><Reference><Citation>Niehrs C. The complex world of WNT receptor signalling. Nat. Rev. Mol. Cell Biol. 2012;13:767&#x2013;779. doi: 10.1038/nrm3470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3470</ArticleId><ArticleId IdType="pubmed">23151663</ArticleId></ArticleIdList></Reference><Reference><Citation>Cadigan K.M., Nusse R. Wnt signaling: A common theme in animal development. Genes Dev. 1997;11:3286&#x2013;3305. doi: 10.1101/gad.11.24.3286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.11.24.3286</ArticleId><ArticleId IdType="pubmed">9407023</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohkawara B., Kobayakawa A., Kanbara S., Hattori T., Kubota S., Ito M., Masuda A., Takigawa M., Lyons K.M., Ishiguro N., et al. CTGF/CCN2 facilitates LRP4-mediated formation of the embryonic neuromuscular junction. EMBO Rep. 2020;21:e48462. doi: 10.15252/embr.201948462.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201948462</ArticleId><ArticleId IdType="pmc">PMC7403661</ArticleId><ArticleId IdType="pubmed">32558157</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuchi A., Yamamoto H., Sato A., Matsumoto S. New insights into the mechanism of Wnt signaling pathway activation. Int. Rev. Cell Mol. Biol. 2011;291:21&#x2013;71. doi: 10.1016/b978-0-12-386035-4.00002-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/b978-0-12-386035-4.00002-1</ArticleId><ArticleId IdType="pubmed">22017973</ArticleId></ArticleIdList></Reference><Reference><Citation>Niessen C.M., Gottardi C.J. Molecular components of the adherens junction. Biochim. Biophys. Acta. 2008;1778:562&#x2013;571. doi: 10.1016/j.bbamem.2007.12.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2007.12.015</ArticleId><ArticleId IdType="pmc">PMC2276178</ArticleId><ArticleId IdType="pubmed">18206110</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanneberger K., Pfister A.S., Brauburger K., Schneikert J., Hadjihannas M.V., Kriz V., Schulte G., Bryja V., Behrens J. Amer1/WTX couples Wnt-induced formation of PtdIns(4,5)P2 to LRP6 phosphorylation. Embo J. 2011;30:1433&#x2013;1443. doi: 10.1038/emboj.2011.28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2011.28</ArticleId><ArticleId IdType="pmc">PMC3102280</ArticleId><ArticleId IdType="pubmed">21304492</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao C., Chen Y.G. Dishevelled: The hub of Wnt signaling. Cell Signal. 2010;22:717&#x2013;727. doi: 10.1016/j.cellsig.2009.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2009.11.021</ArticleId><ArticleId IdType="pubmed">20006983</ArticleId></ArticleIdList></Reference><Reference><Citation>Aberle H., Bauer A., Stappert J., Kispert A., Kemler R. beta-catenin is a target for the ubiquitin-proteasome pathway. Embo J. 1997;16:3797&#x2013;3804. doi: 10.1093/emboj/16.13.3797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/16.13.3797</ArticleId><ArticleId IdType="pmc">PMC1170003</ArticleId><ArticleId IdType="pubmed">9233789</ArticleId></ArticleIdList></Reference><Reference><Citation>Cadigan K.M., Waterman M.L. TCF/LEFs and Wnt signaling in the nucleus. Cold Spring Harb. Perspect. Biol. 2012;4 doi: 10.1101/cshperspect.a007906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a007906</ArticleId><ArticleId IdType="pmc">PMC3536346</ArticleId><ArticleId IdType="pubmed">23024173</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlad A., R&#xf6;hrs S., Klein-Hitpass L., M&#xfc;ller O. The first five years of the Wnt targetome. Cell Signal. 2008;20:795&#x2013;802. doi: 10.1016/j.cellsig.2007.10.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2007.10.031</ArticleId><ArticleId IdType="pubmed">18160255</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald B.T., Tamai K., He X. Wnt/beta-catenin signaling: Components, mechanisms, and diseases. Dev. Cell. 2009;17:9&#x2013;26. doi: 10.1016/j.devcel.2009.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2009.06.016</ArticleId><ArticleId IdType="pmc">PMC2861485</ArticleId><ArticleId IdType="pubmed">19619488</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattes B., Dang Y., Greicius G., Kaufmann L.T., Prunsche B., Rosenbauer J., Stegmaier J., Mikut R., &#xd6;zbek S., Nienhaus G.U., et al. Wnt/PCP controls spreading of Wnt/&#x3b2;-catenin signals by cytonemes in vertebrates. eLife. 2018;7 doi: 10.7554/eLife.36953.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.36953</ArticleId><ArticleId IdType="pmc">PMC6086664</ArticleId><ArticleId IdType="pubmed">30060804</ArticleId></ArticleIdList></Reference><Reference><Citation>De A. Wnt/Ca2+ signaling pathway: A brief overview. Acta Biochim. Biophys. Sin. 2011;43:745&#x2013;756. doi: 10.1093/abbs/gmr079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/abbs/gmr079</ArticleId><ArticleId IdType="pubmed">21903638</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheldahl L.C., Park M., Malbon C.C., Moon R.T. Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner. Curr. Biol. 1999;9:695&#x2013;698. doi: 10.1016/S0960-9822(99)80310-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(99)80310-8</ArticleId><ArticleId IdType="pubmed">10395542</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun A.P., Schulman H. The multifunctional calcium/calmodulin-dependent protein kinase: From form to function. Annu. Rev. Physiol. 1995;57:417&#x2013;445. doi: 10.1146/annurev.ph.57.030195.002221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.ph.57.030195.002221</ArticleId><ArticleId IdType="pubmed">7778873</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirabayashi Y., Itoh Y., Tabata H., Nakajima K., Akiyama T., Masuyama N., Gotoh Y. The Wnt/beta-catenin pathway directs neuronal differentiation of cortical neural precursor cells. Development. 2004;131:2791&#x2013;2801. doi: 10.1242/dev.01165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.01165</ArticleId><ArticleId IdType="pubmed">15142975</ArticleId></ArticleIdList></Reference><Reference><Citation>Meffre D., Grenier J., Bernard S., Courtin F., Dudev T., Shackleford G., Jafarian-Tehrani M., Massaad C. Wnt and lithium: A common destiny in the therapy of nervous system pathologies? Cell Mol. Life Sci. 2014;71:1123&#x2013;1148. doi: 10.1007/s00018-013-1378-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1378-1</ArticleId><ArticleId IdType="pubmed">23749084</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L., Guan Y., Wu X., Chen Y., Liu Z., Du H., Wang X. Wnt Signaling is altered by spinal cord neuronal dysfunction in amyotrophic lateral sclerosis transgenic mice. Neurochem. Res. 2013;38:1904&#x2013;1913. doi: 10.1007/s11064-013-1096-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-013-1096-y</ArticleId><ArticleId IdType="pmc">PMC4170800</ArticleId><ArticleId IdType="pubmed">23784673</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Guan Y., Chen Y., Zhang C., Shi C., Zhou F., Yu L., Juan J., Wang X. Expression of Wnt5a and its receptor Fzd2 is changed in the spinal cord of adult amyotrophic lateral sclerosis transgenic mice. Int. J. Clin. Exp. Pathol. 2013;6:1245&#x2013;1260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3693190</ArticleId><ArticleId IdType="pubmed">23826406</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Guan Y., Liu H., Wu X., Yu L., Wang S., Zhao C., Du H., Wang X. Activation of the Wnt/&#x3b2;-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice. Biochem. Biophys. Res. Commun. 2012;420:397&#x2013;403. doi: 10.1016/j.bbrc.2012.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2012.03.006</ArticleId><ArticleId IdType="pubmed">22426476</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Guan Y., Zhang Z., Liu H., Wang S., Yu L., Wu X., Wang X. Wnt signaling pathway is involved in the pathogenesis of amyotrophic lateral sclerosis in adult transgenic mice. Neurol. Res. 2012;34:390&#x2013;399. doi: 10.1179/1743132812Y.0000000027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/1743132812Y.0000000027</ArticleId><ArticleId IdType="pubmed">22643084</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Guan Y., Chen Y., Li X., Zhang C., Yu L., Zhou F., Wang X. Role of Wnt1 and Fzd1 in the spinal cord pathogenesis of amyotrophic lateral sclerosis-transgenic mice. Biotechnol. Lett. 2013;35:1199&#x2013;1207. doi: 10.1007/s10529-013-1199-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10529-013-1199-1</ArticleId><ArticleId IdType="pubmed">23553522</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripps M.E., Huntley G.W., Hof P.R., Morrison J.H., Gordon J.W. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 1995;92:689&#x2013;693. doi: 10.1073/pnas.92.3.689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.92.3.689</ArticleId><ArticleId IdType="pmc">PMC42685</ArticleId><ArticleId IdType="pubmed">7846037</ArticleId></ArticleIdList></Reference><Reference><Citation>Dal Canto M.C., Gurney M.E. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am. J. Pathol. 1994;145:1271&#x2013;1279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1887498</ArticleId><ArticleId IdType="pubmed">7992831</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto C., Medinas D.B., Fuentes-Villalobos F., Maripill&#xe1;n J., Castro A.F., Mart&#xed;nez A.D., Osses N., Hetz C., Henr&#xed;quez J.P. &#x3b2;-catenin aggregation in models of ALS motor neurons: GSK3&#x3b2; inhibition effect and neuronal differentiation. Neuro Biol. Dis. 2019;130:104497. doi: 10.1016/j.nbd.2019.104497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104497</ArticleId><ArticleId IdType="pubmed">31176720</ArticleId></ArticleIdList></Reference><Reference><Citation>Veeman M.T., Axelrod J.D., Moon R.T. A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev. Cell. 2003;5:367&#x2013;377. doi: 10.1016/S1534-5807(03)00266-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1534-5807(03)00266-1</ArticleId><ArticleId IdType="pubmed">12967557</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira C., Schaer D.J., Bachli E.B., Kurrer M.O., Schoedon G. Wnt5A/CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10. Arterioscler. Thromb. Vasc. Biol. 2008;28:504&#x2013;510. doi: 10.1161/ATVBAHA.107.157438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.107.157438</ArticleId><ArticleId IdType="pubmed">18174455</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Fern&#xe1;ndez C., Gonzalez P., Andres-Benito P., Ferrer I., Rodr&#xed;guez F.J. Wnt Signaling Alterations in the Human Spinal Cord of Amyotrophic Lateral Sclerosis Cases: Spotlight on Fz2 and Wnt5a. Mol. NeuroBiol. 2019;56:6777&#x2013;6791. doi: 10.1007/s12035-019-1547-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1547-9</ArticleId><ArticleId IdType="pubmed">30924074</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Wang Y., Smallwood P.M., Nathans J. An essential role for Frizzled5 in neuronal survival in the parafascicular nucleus of the thalamus. J. NeuroSci. 2008;28:5641&#x2013;5653. doi: 10.1523/JNEUROSCI.1056-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1056-08.2008</ArticleId><ArticleId IdType="pmc">PMC6670808</ArticleId><ArticleId IdType="pubmed">18509025</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahores M., Gibb A., Salinas P.C. Frizzled-5, a receptor for the synaptic organizer Wnt7a, regulates activity-mediated synaptogenesis. Development. 2010;137:2215&#x2013;2225. doi: 10.1242/dev.046722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.046722</ArticleId><ArticleId IdType="pmc">PMC2882138</ArticleId><ArticleId IdType="pubmed">20530549</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Fern&#xe1;ndez C., Mancuso R., Del Valle J., Navarro X., Rodr&#xed;guez F.J. Wnt Signaling Alteration in the Spinal Cord of Amyotrophic Lateral Sclerosis Transgenic Mice: Special Focus on Frizzled-5 Cellular Expression Pattern. PLoS ONE. 2016;11:e0155867. doi: 10.1371/journal.pone.0155867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0155867</ArticleId><ArticleId IdType="pmc">PMC4871528</ArticleId><ArticleId IdType="pubmed">27192435</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinonen K.M., Vanegas J.R., Lew D., Krosl J., Perreault C. Wnt4 enhances murine hematopoietic progenitor cell expansion through a planar cell polarity-like pathway. PLoS ONE. 2011;6:e19279. doi: 10.1371/journal.pone.0019279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0019279</ArticleId><ArticleId IdType="pmc">PMC3082562</ArticleId><ArticleId IdType="pubmed">21541287</ArticleId></ArticleIdList></Reference><Reference><Citation>Mess&#xe9;ant J., Ezan J., Delers P., Glebov K., Marchiol C., Lager F., Renault G., Tissir F., Montcouquiol M., Sans N., et al. Wnt proteins contribute to neuromuscular junction formation through distinct signaling pathways. Development. 2017;144:1712&#x2013;1724. doi: 10.1242/dev.146167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.146167</ArticleId><ArticleId IdType="pubmed">28348167</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira G.P., Maximino J.R., Maschietto M., Zanoteli E., Puga R.D., Lima L., Carraro D.M., Chadi G. Early gene expression changes in skeletal muscle from SOD1(G93A) amyotrophic lateral sclerosis animal model. Cell Mol. NeuroBiol. 2014;34:451&#x2013;462. doi: 10.1007/s10571-014-0029-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-014-0029-x</ArticleId><ArticleId IdType="pubmed">24442855</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhinge A., Namboori S.C., Zhang X., VanDongen A.M.J., Stanton L.W. Genetic Correction of SOD1 Mutant iPSCs Reveals ERK and JNK Activated AP1 as a Driver of Neurodegeneration in Amyotrophic Lateral Sclerosis. Stem Cell Rep. 2017;8:856&#x2013;869. doi: 10.1016/j.stemcr.2017.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.02.019</ArticleId><ArticleId IdType="pmc">PMC5390134</ArticleId><ArticleId IdType="pubmed">28366453</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.E., Hong Y.H., Kim J.Y., Jeon G.S., Jung J.H., Yoon B.N., Son S.Y., Lee K.W., Kim J.I., Sung J.J. Altered nucleocytoplasmic proteome and transcriptome distributions in an in vitro model of amyotrophic lateral sclerosis. PLoS ONE. 2017;12:e0176462. doi: 10.1371/journal.pone.0176462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0176462</ArticleId><ArticleId IdType="pmc">PMC5409181</ArticleId><ArticleId IdType="pubmed">28453527</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan T., Kazamel M., Thoenes K., Si Y., Jiang N., King P.H. Wnt antagonist FRZB is a muscle biomarker of denervation atrophy in amyotrophic lateral sclerosis. Sci. Rep. 2020;10:16679. doi: 10.1038/s41598-020-73845-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-73845-z</ArticleId><ArticleId IdType="pmc">PMC7541525</ArticleId><ArticleId IdType="pubmed">33028902</ArticleId></ArticleIdList></Reference><Reference><Citation>McLoon L.K., Harandi V.M., Br&#xe4;nnstr&#xf6;m T., Andersen P.M., Liu J.X. Wnt and extraocular muscle sparing in amyotrophic lateral sclerosis. Investig. Ophthalmol. Vis. Sci. 2014;55:5482&#x2013;5496. doi: 10.1167/iovs.14-14886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.14-14886</ArticleId><ArticleId IdType="pmc">PMC4580151</ArticleId><ArticleId IdType="pubmed">25125606</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzartos J.S., Zisimopoulou P., Rentzos M., Karandreas N., Zouvelou V., Evangelakou P., Tsonis A., Thomaidis T., Lauria G., Andreetta F., et al. LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients. Ann. Clin. Transl. Neurol. 2014;1:80&#x2013;87. doi: 10.1002/acn3.26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.26</ArticleId><ArticleId IdType="pmc">PMC4212481</ArticleId><ArticleId IdType="pubmed">25356387</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei L., Shen X.M., Wang S.Y., Lu Y., Wang S.B., Chen H., Liu Z., Ouyang Y.S., Duo J.Y., Da Y.W., et al. Presence of antibodies against low-density lipoprotein receptor-related protein 4 and impairment of neuromuscular junction in a Chinese cohort of amyotrophic lateral sclerosis. Chin. Med. J. 2019;132:1487&#x2013;1489. doi: 10.1097/CM9.0000000000000284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000000284</ArticleId><ArticleId IdType="pmc">PMC6629318</ArticleId><ArticleId IdType="pubmed">31205110</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto C., C&#xe1;rdenas P., Osses N., Henr&#xed;quez J.P. Characterization of Wnt/&#x3b2;-catenin and BMP/Smad signaling pathways in an in vitro model of amyotrophic lateral sclerosis. Front. Cell NeuroSci. 2013;7:239. doi: 10.3389/fncel.2013.00239.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00239</ArticleId><ArticleId IdType="pmc">PMC3847560</ArticleId><ArticleId IdType="pubmed">24348333</ArticleId></ArticleIdList></Reference><Reference><Citation>Godin J.D., Poizat G., Hickey M.A., Maschat F., Humbert S. Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington&#x2019;s disease. Embo J. 2010;29:2433&#x2013;2445. doi: 10.1038/emboj.2010.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.117</ArticleId><ArticleId IdType="pmc">PMC2910267</ArticleId><ArticleId IdType="pubmed">20531388</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia L., Pi&#xf1;a-Crespo J., Li Y. Restoring Wnt/&#x3b2;-catenin signaling is a promising therapeutic strategy for Alzheimer&#x2019;s disease. Mol. Brain. 2019;12:104. doi: 10.1186/s13041-019-0525-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-019-0525-5</ArticleId><ArticleId IdType="pmc">PMC6894260</ArticleId><ArticleId IdType="pubmed">31801553</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackburn D., Sargsyan S., Monk P.N., Shaw P.J. Astrocyte function and role in motor neuron disease: A future therapeutic target? Glia. 2009;57:1251&#x2013;1264. doi: 10.1002/glia.20848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20848</ArticleId><ArticleId IdType="pubmed">19373940</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas M.R., Johnson D.A., Sirkis D.W., Messing A., Johnson J.A. Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J. NeuroSci. 2008;28:13574&#x2013;13581. doi: 10.1523/JNEUROSCI.4099-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4099-08.2008</ArticleId><ArticleId IdType="pmc">PMC2866507</ArticleId><ArticleId IdType="pubmed">19074031</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Fotinos A., Wu Q., Chen Y., Zhu Y., Baranov S., Tu Y., Zhou E.W., Sinha B., Kristal B.S., et al. N-acetyl-L-tryptophan delays disease onset and extends survival in an amyotrophic lateral sclerosis transgenic mouse model. NeuroBiol. Dis. 2015;80:93&#x2013;103. doi: 10.1016/j.nbd.2015.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.05.002</ArticleId><ArticleId IdType="pubmed">25986728</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Cook A., Kim J., Baranov S.V., Jiang J., Smith K., Cormier K., Bennett E., Browser R.P., Day A.L., et al. Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis. NeuroBiol. Dis. 2013;55:26&#x2013;35. doi: 10.1016/j.nbd.2013.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.03.008</ArticleId><ArticleId IdType="pmc">PMC3652329</ArticleId><ArticleId IdType="pubmed">23537713</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofroniew M.V. Astrogliosis. Cold Spring Harb. Perspect. Biol. 2014;7:a020420. doi: 10.1101/cshperspect.a020420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a020420</ArticleId><ArticleId IdType="pmc">PMC4315924</ArticleId><ArticleId IdType="pubmed">25380660</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M., Re D.B., Nagata T., Chalazonitis A., Jessell T.M., Wichterle H., Przedborski S. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. NeuroSci. 2007;10:615&#x2013;622. doi: 10.1038/nn1876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1876</ArticleId><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy D., Kato T., Kushner P.D. Reactive astrocytes are widespread in the cortical gray matter of amyotrophic lateral sclerosis. J. NeuroSci. Res. 1994;38:336&#x2013;347. doi: 10.1002/jnr.490380312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.490380312</ArticleId><ArticleId IdType="pubmed">7523689</ArticleId></ArticleIdList></Reference><Reference><Citation>Valori C.F., Guidotti G., Brambilla L., Rossi D. Astrocytes in Motor Neuron Diseases. Adv. Exp. Med. Biol. 2019;1175:227&#x2013;272. doi: 10.1007/978-981-13-9913-8_10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-13-9913-8_10</ArticleId><ArticleId IdType="pubmed">31583591</ArticleId></ArticleIdList></Reference><Reference><Citation>Pehar M., Harlan B.A., Killoy K.M., Vargas M.R. Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis. Curr. Pharm. Des. 2017;23:5010&#x2013;5021. doi: 10.2174/1381612823666170622095802.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612823666170622095802</ArticleId><ArticleId IdType="pmc">PMC5740017</ArticleId><ArticleId IdType="pubmed">28641533</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S., Zhu X.J., Huang H., Guo W., Tang T., Xie B., Xu X., Zhang Z., Shen Y., Dai Z.M., et al. WNT signaling represses astrogliogenesis via Ngn2-dependent direct suppression of astrocyte gene expression. Glia. 2019;67:1333&#x2013;1343. doi: 10.1002/glia.23608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23608</ArticleId><ArticleId IdType="pubmed">30889310</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller S.J., Glatzer J.C., Hsieh Y.C., Rothstein J.D. Cortical astroglia undergo transcriptomic dysregulation in the G93A SOD1 ALS mouse model. J. Neurogenet. 2018;32:322&#x2013;335. doi: 10.1080/01677063.2018.1513508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01677063.2018.1513508</ArticleId><ArticleId IdType="pmc">PMC6444185</ArticleId><ArticleId IdType="pubmed">30398075</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 1995;38:73&#x2013;84. doi: 10.1002/ana.410380114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410380114</ArticleId><ArticleId IdType="pubmed">7611729</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein J.D., Tsai G., Kuncl R.W., Clawson L., Cornblath D.R., Drachman D.B., Pestronk A., Stauch B.L., Coyle J.T. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 1990;28:18&#x2013;25. doi: 10.1002/ana.410280106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410280106</ArticleId><ArticleId IdType="pubmed">2375630</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkin G.M., Udawela M., Gibbons A., Dean B. Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders. World J. Psychiatry. 2018;8:51&#x2013;63. doi: 10.5498/wjp.v8.i2.51.</Citation><ArticleIdList><ArticleId IdType="doi">10.5498/wjp.v8.i2.51</ArticleId><ArticleId IdType="pmc">PMC6033743</ArticleId><ArticleId IdType="pubmed">29988908</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei L., Chen C., Ding L., Mo M., Zou J., Lu Z., Li H., Wu H., Dai Y., Xu P., et al. Wnt1 Promotes EAAT2 Expression and Mediates the Protective Effects of Astrocytes on Dopaminergic Cells in Parkinson&#x2019;s Disease. Neural. Plast. 2019;2019:1247276. doi: 10.1155/2019/1247276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/1247276</ArticleId><ArticleId IdType="pmc">PMC6754970</ArticleId><ArticleId IdType="pubmed">31582965</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.G., Su Z.Z., Emdad L., Gupta P., Sarkar D., Borjabad A., Volsky D.J., Fisher P.B. Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes. J. Biol. Chem. 2008;283:13116&#x2013;13123. doi: 10.1074/jbc.M707697200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M707697200</ArticleId><ArticleId IdType="pmc">PMC2442320</ArticleId><ArticleId IdType="pubmed">18326497</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry J.D., Shefner J.M., Conwit R., Schoenfeld D., Keroack M., Felsenstein D., Krivickas L., David W.S., Vriesendorp F., Pestronk A., et al. Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis. PLoS ONE. 2013;8:e61177. doi: 10.1371/journal.pone.0061177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0061177</ArticleId><ArticleId IdType="pmc">PMC3629222</ArticleId><ArticleId IdType="pubmed">23613806</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X.D., Li L., Liu F., Huang Z.H., Bean J.C., Jiao H.F., Barik A., Kim S.M., Wu H., Shen C., et al. Lrp4 in astrocytes modulates glutamatergic transmission. Nat. NeuroSci. 2016;19:1010&#x2013;1018. doi: 10.1038/nn.4326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4326</ArticleId><ArticleId IdType="pmc">PMC4961622</ArticleId><ArticleId IdType="pubmed">27294513</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Bento-Abreu A., Nonneman A., Haeck W., Staats K., Geelen V., Hersmus N., K&#xfc;sters B., Van Den Bosch L., Van Damme P., et al. Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis. Brain. 2013;136:471&#x2013;482. doi: 10.1093/brain/aws339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws339</ArticleId><ArticleId IdType="pmc">PMC3572934</ArticleId><ArticleId IdType="pubmed">23378219</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S.H., Li Y., Fukaya M., Lorenzini I., Cleveland D.W., Ostrow L.W., Rothstein J.D., Bergles D.E. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat. NeuroSci. 2013;16:571&#x2013;579. doi: 10.1038/nn.3357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3357</ArticleId><ArticleId IdType="pmc">PMC3637847</ArticleId><ArticleId IdType="pubmed">23542689</ArticleId></ArticleIdList></Reference><Reference><Citation>Nave K.A. Myelination and support of axonal integrity by glia. Nature. 2010;468:244&#x2013;252. doi: 10.1038/nature09614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09614</ArticleId><ArticleId IdType="pubmed">21068833</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y., Morrison B.M., Li Y., Lengacher S., Farah M.H., Hoffman P.N., Liu Y., Tsingalia A., Jin L., Zhang P.W., et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature. 2012;487:443&#x2013;448. doi: 10.1038/nature11314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11314</ArticleId><ArticleId IdType="pmc">PMC3408792</ArticleId><ArticleId IdType="pubmed">22801498</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonneman A., Robberecht W., Van Den Bosch L. The role of oligodendroglial dysfunction in amyotrophic lateral sclerosis. Neurodegener. Dis. Manag. 2014;4:223&#x2013;239. doi: 10.2217/nmt.14.21.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nmt.14.21</ArticleId><ArticleId IdType="pubmed">25095817</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega F., Gasc&#xf3;n S., Masserdotti G., Deshpande A., Simon C., Fischer J., Dimou L., Chichung Lie D., Schroeder T., Berninger B. Oligodendrogliogenic and neurogenic adult subependymal zone neural stem cells constitute distinct lineages and exhibit differential responsiveness to Wnt signalling. Nat. Cell Biol. 2013;15:602&#x2013;613. doi: 10.1038/ncb2736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2736</ArticleId><ArticleId IdType="pubmed">23644466</ArticleId></ArticleIdList></Reference><Reference><Citation>Azim K., Butt A.M. GSK3&#x3b2; negatively regulates oligodendrocyte differentiation and myelination in vivo. Glia. 2011;59:540&#x2013;553. doi: 10.1002/glia.21122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.21122</ArticleId><ArticleId IdType="pubmed">21319221</ArticleId></ArticleIdList></Reference><Reference><Citation>Makoukji J., Belle M., Meffre D., Stassart R., Grenier J., Shackleford G., Fledrich R., Fonte C., Branchu J., Goulard M., et al. Lithium enhances remyelination of peripheral nerves. Proc. Natl. Acad. Sci. USA. 2012;109:3973&#x2013;3978. doi: 10.1073/pnas.1121367109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1121367109</ArticleId><ArticleId IdType="pmc">PMC3309729</ArticleId><ArticleId IdType="pubmed">22355115</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T., Kagawa T., Wada T., Muroyama Y., Takada S., Ikenaka K. Wnt signaling controls the timing of oligodendrocyte development in the spinal cord. Dev. Biol. 2005;282:397&#x2013;410. doi: 10.1016/j.ydbio.2005.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2005.03.020</ArticleId><ArticleId IdType="pubmed">15950605</ArticleId></ArticleIdList></Reference><Reference><Citation>Feigenson K., Reid M., See J., Crenshaw E.B., 3rd, Grinspan J.B. Wnt signaling is sufficient to perturb oligodendrocyte maturation. Mol. Cell NeuroSci. 2009;42:255&#x2013;265. doi: 10.1016/j.mcn.2009.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2009.07.010</ArticleId><ArticleId IdType="pubmed">19619658</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye F., Chen Y., Hoang T., Montgomery R.L., Zhao X.H., Bu H., Hu T., Taketo M.M., van Es J.H., Clevers H., et al. HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nat. NeuroSci. 2009;12:829&#x2013;838. doi: 10.1038/nn.2333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2333</ArticleId><ArticleId IdType="pmc">PMC2701973</ArticleId><ArticleId IdType="pubmed">19503085</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata T., Akiyama H., Yamada T., McGeer P.L. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am. J. Pathol. 1992;140:691&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1886170</ArticleId><ArticleId IdType="pubmed">1347673</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Cagnin A., Turkheimer F.E., Miller C.C., Shaw C.E., Brooks D.J., Leigh P.N., Banati R.B. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: An [11C](R)-PK11195 positron emission tomography study. NeuroBiol. Dis. 2004;15:601&#x2013;609. doi: 10.1016/j.nbd.2003.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2003.12.012</ArticleId><ArticleId IdType="pubmed">15056468</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivest S. Regulation of innate immune responses in the brain. Nat. Rev. Immunol. 2009;9:429&#x2013;439. doi: 10.1038/nri2565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2565</ArticleId><ArticleId IdType="pubmed">19461673</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanisch U.K., Kettenmann H. Microglia: Active sensor and versatile effector cells in the normal and pathologic brain. Nat. NeuroSci. 2007;10:1387&#x2013;1394. doi: 10.1038/nn1997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1997</ArticleId><ArticleId IdType="pubmed">17965659</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes A.E., Ferraiuolo L., Haidet-Phillips A.M., Schmelzer L., Braun L., Miranda C.J., Ladner K.J., Bevan A.K., Foust K.D., Godbout J.P., et al. Microglia induce motor neuron death via the classical NF-&#x3ba;B pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009&#x2013;1023. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall E.D., Oostveen J.A., Gurney M.E. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia. 1998;23:249&#x2013;256. doi: 10.1002/(SICI)1098-1136(199807)23:3&lt;249::AID-GLIA7&gt;3.0.CO;2-#.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1098-1136(199807)23:3&lt;249::AID-GLIA7&gt;3.0.CO;2-#</ArticleId><ArticleId IdType="pubmed">9633809</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouali Alami N., Schurr C., Olde Heuvel F., Tang L., Li Q., Tasdogan A., Kimbara A., Nettekoven M., Ottaviani G., Raposo C., et al. NF-&#x3ba;B activation in astrocytes drives a stage-specific beneficial neuroimmunological response in ALS. Embo J. 2018;37 doi: 10.15252/embj.201798697.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201798697</ArticleId><ArticleId IdType="pmc">PMC6092622</ArticleId><ArticleId IdType="pubmed">29875132</ArticleId></ArticleIdList></Reference><Reference><Citation>Halleskog C., Dijksterhuis J.P., Kilander M.B., Becerril-Ortega J., Villaescusa J.C., Lindgren E., Arenas E., Schulte G. Heterotrimeric G protein-dependent WNT-5A signaling to ERK1/2 mediates distinct aspects of microglia proinflammatory transformation. J. Neuroinflamm. 2012;9:111. doi: 10.1186/1742-2094-9-111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-9-111</ArticleId><ArticleId IdType="pmc">PMC3458933</ArticleId><ArticleId IdType="pubmed">22647544</ArticleId></ArticleIdList></Reference><Reference><Citation>Halleskog C., Mulder J., Dahlstr&#xf6;m J., Mackie K., Hortob&#xe1;gyi T., Tanila H., Kumar Puli L., F&#xe4;rber K., Harkany T., Schulte G. WNT signaling in activated microglia is proinflammatory. Glia. 2011;59:119&#x2013;131. doi: 10.1002/glia.21081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.21081</ArticleId><ArticleId IdType="pmc">PMC3064522</ArticleId><ArticleId IdType="pubmed">20967887</ArticleId></ArticleIdList></Reference><Reference><Citation>Song D., Zhang X., Chen J., Liu X., Xue J., Zhang L., Lan X. Wnt canonical pathway activator TWS119 drives microglial anti-inflammatory activation and facilitates neurological recovery following experimental stroke. J. Neuroinflamm. 2019;16:256. doi: 10.1186/s12974-019-1660-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1660-8</ArticleId><ArticleId IdType="pmc">PMC6896312</ArticleId><ArticleId IdType="pubmed">31810470</ArticleId></ArticleIdList></Reference><Reference><Citation>Akiyama T., Suzuki N., Ishikawa M., Fujimori K., Sone T., Kawada J., Funayama R., Fujishima F., Mitsuzawa S., Ikeda K., et al. Aberrant axon branching via Fos-B dysregulation in FUS-ALS motor neurons. EBioMedicine. 2019;45:362&#x2013;378. doi: 10.1016/j.ebiom.2019.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.06.013</ArticleId><ArticleId IdType="pmc">PMC6642224</ArticleId><ArticleId IdType="pubmed">31262712</ArticleId></ArticleIdList></Reference><Reference><Citation>Onishi K., Hollis E., Zou Y. Axon guidance and injury-lessons from Wnts and Wnt signaling. Curr. Opin NeuroBiol. 2014;27:232&#x2013;240. doi: 10.1016/j.conb.2014.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2014.05.005</ArticleId><ArticleId IdType="pmc">PMC4337865</ArticleId><ArticleId IdType="pubmed">24927490</ArticleId></ArticleIdList></Reference><Reference><Citation>Tury A., Tolentino K., Zou Y. Altered expression of atypical PKC and Ryk in the spinal cord of a mouse model of amyotrophic lateral sclerosis. Dev. NeuroBiol. 2014;74:839&#x2013;850. doi: 10.1002/dneu.22137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dneu.22137</ArticleId><ArticleId IdType="pmc">PMC4099310</ArticleId><ArticleId IdType="pubmed">24123880</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Wang X., Lu C.C., Kerman R., Steward O., Xu X.M., Zou Y. Repulsive Wnt signaling inhibits axon regeneration after CNS injury. J. NeuroSci. 2008;28:8376&#x2013;8382. doi: 10.1523/JNEUROSCI.1939-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1939-08.2008</ArticleId><ArticleId IdType="pmc">PMC3385642</ArticleId><ArticleId IdType="pubmed">18701700</ArticleId></ArticleIdList></Reference><Reference><Citation>Picchiarelli G., Demestre M., Zuko A., Been M., Higelin J., Dieterl&#xe9; S., Goy M.A., Mallik M., Sellier C., Scekic-Zahirovic J., et al. FUS-mediated regulation of acetylcholine receptor transcription at neuromuscular junctions is compromised in amyotrophic lateral sclerosis. Nat. NeuroSci. 2019;22:1793&#x2013;1805. doi: 10.1038/s41593-019-0498-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0498-9</ArticleId><ArticleId IdType="pmc">PMC6858880</ArticleId><ArticleId IdType="pubmed">31591561</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Ito M., Ohkawara B., Masuda A., Ohno K. Differential effects of spinal motor neuron-derived and skeletal muscle-derived Rspo2 on acetylcholine receptor clustering at the neuromuscular junction. Sci. Rep. 2018;8:13577. doi: 10.1038/s41598-018-31949-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31949-7</ArticleId><ArticleId IdType="pmc">PMC6133930</ArticleId><ArticleId IdType="pubmed">30206360</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Arber S., William C., Li L., Tanabe Y., Jessell T.M., Birchmeier C., Burden S.J. Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation. Neuron. 2001;30:399&#x2013;410. doi: 10.1016/S0896-6273(01)00287-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(01)00287-2</ArticleId><ArticleId IdType="pubmed">11395002</ArticleId></ArticleIdList></Reference><Reference><Citation>Burden S.J. SnapShot: Neuromuscular Junction. Cell. 2011;144:826.e821. doi: 10.1016/j.cell.2011.02.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.02.037</ArticleId><ArticleId IdType="pubmed">21376240</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon L.R., Gribble K.D., Syrett C.M., Granato M. Initiation of synapse formation by Wnt-induced MuSK endocytosis. Development. 2012;139:1023&#x2013;1033. doi: 10.1242/dev.071555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.071555</ArticleId><ArticleId IdType="pmc">PMC3274363</ArticleId><ArticleId IdType="pubmed">22318632</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriquez J.P., Webb A., Bence M., Bildsoe H., Sahores M., Hughes S.M., Salinas P.C. Wnt signaling promotes AChR aggregation at the neuromuscular synapse in collaboration with agrin. Proc. Natl. Acad. Sci. USA. 2008;105:18812&#x2013;18817. doi: 10.1073/pnas.0806300105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0806300105</ArticleId><ArticleId IdType="pmc">PMC2585041</ArticleId><ArticleId IdType="pubmed">19020093</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Ruan N.J., Qian L., Lei W.L., Chen F., Luo Z.G. Wnt/beta-catenin signaling suppresses Rapsyn expression and inhibits acetylcholine receptor clustering at the neuromuscular junction. J. Biol. Chem. 2008;283:21668&#x2013;21675. doi: 10.1074/jbc.M709939200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M709939200</ArticleId><ArticleId IdType="pubmed">18541538</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Garc&#xed;a M.J., Burden S.J. Increasing MuSK activity delays denervation and improves motor function in ALS mice. Cell Rep. 2012;2:497&#x2013;502. doi: 10.1016/j.celrep.2012.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.08.004</ArticleId><ArticleId IdType="pmc">PMC3462266</ArticleId><ArticleId IdType="pubmed">22939980</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantor S., Zhang W., Delestr&#xe9;e N., Rem&#xe9;dio L., Mentis G.Z., Burden S.J. Preserving neuromuscular synapses in ALS by stimulating MuSK with a therapeutic agonist antibody. eLife. 2018;7 doi: 10.7554/eLife.34375.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.34375</ArticleId><ArticleId IdType="pmc">PMC5837562</ArticleId><ArticleId IdType="pubmed">29460776</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta-Ghosh A., Dominguez S.L., Xie L., Barck K.H., Jiang Z., Earr T., Imperio J., Phu L., Budayeva H.G., Kirkpatrick D.S., et al. Muscle specific kinase (MuSK) activation preserves neuromuscular junctions in the diaphragm but is not sufficient to provide a functional benefit in the SOD1(G93A) mouse model of ALS. NeuroBiol. Dis. 2019;124:340&#x2013;352. doi: 10.1016/j.nbd.2018.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.12.002</ArticleId><ArticleId IdType="pubmed">30528255</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>